A new study found that atogepant, a migraine prevention drug, reduces migraine days and improves daily function within 4 weeks, offering hope for faster relief for sufferers.
A new study found that atogepant, a migraine prevention drug, reduces migraine days and improves daily function within 4 weeks, offering hope for faster relief for sufferers.